April 26, 2019
Rose
There's been more and more scrutiny over how pharma companies use patents to find loopholes in anti-competition laws. Now Sen. John Cornyn (R-Texas) is going after a practice where companies make minor formula adjustments to prevent generic substitutions. In other pharmaceutical news: more kickback settlements, pharma-funded charities, first-quarter profits, copays and more.
from Kaiser Health News http://bit.ly/2vmYTR1
April 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘Staying Away From Grandma’ Isn’t An Option In Multigenerational Homes- Mysterious Heart Damage, Not Just Lung Troubles, Befalling COVID-19 Patients
- Long-Standing Racial And Income Disparities Seen Creeping Into COVID-19 Care
- Medicaid en el “ojo de la tormenta” por nuevos desempleados que buscan cobertura
- Longer Looks: The Taliban And The Coronavirus; Medical Possibilities Of An Underwater Forest; The Perfect High
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment